These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30005210)

  • 21. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
    Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
    J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR.
    Zhou D; Zhu X; Wu X; Zheng J; Tou L; Zhou Y
    Exp Ther Med; 2021 Aug; 22(2):798. PubMed ID: 34093754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer.
    Yang Z; Sun Y; Liu R; Shi Y; Ding S
    Cancer Manag Res; 2019; 11():6175-6184. PubMed ID: 31308753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA Expression Profiling in Advanced Resected Gastric Adenocarcinoma Tissues.
    Dang Y; Lin L; Ouyang X; Zhang F; Chen S; Wang B; Zhang Z; Chen S; Deng L; Wang W; Wang L; Xiao C; Qi Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating long non-coding RNAs HULC and ZNFX1-AS1 are potential biomarkers in patients with gastric cancer.
    Xian HP; Zhuo ZL; Sun YJ; Liang B; Zhao XT
    Oncol Lett; 2018 Oct; 16(4):4689-4698. PubMed ID: 30197680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
    Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
    Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FENDRR: A pivotal, cancer-related, long non-coding RNA.
    Zheng Q; Zhang Q; Yu X; He Y; Guo W
    Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.
    Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW
    Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
    Zheng L; Chen J; Zhou Z; He Z
    Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
    Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
    Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis.
    Zhou Q; Li H; Jing J; Yuan Y; Sun L
    Onco Targets Ther; 2020; 13():2795-2805. PubMed ID: 32308414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revealing the Role of lncRNA CCDC144NL-AS1 and LINC01614 in Gastric Cancer
    Sheng W; Zhou W; Cao Y; Zhong Y
    Front Oncol; 2021; 11():769563. PubMed ID: 35083139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative Analysis of Dysregulated lncRNA-Associated ceRNA Network Reveals Functional lncRNAs in Gastric Cancer.
    Liu H; Zhang Z; Wu N; Guo H; Zhang H; Fan D; Nie Y; Liu Y
    Genes (Basel); 2018 Jun; 9(6):. PubMed ID: 29912172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel long non-coding RNA TONSL-AS1 regulates progression of gastric cancer via activating TONSL.
    Wang P; Yang X; Zhao L; Liu D; Liu J; Ding Y
    Exp Cell Res; 2019 Sep; 382(1):111453. PubMed ID: 31158361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.